Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV - PubMed (original) (raw)
Review
Biomarkers of semen in the vagina: applications in clinical trials of contraception and prevention of sexually transmitted pathogens including HIV
Christine K Mauck et al. Contraception. 2007 Jun.
Abstract
Biomarkers of vaginal exposure to semen, long used in forensic medicine, are now becoming important in the development of vaginal microbicides to prevent HIV/STIs and the development of contraceptives. Semen biomarkers could help evaluate the safety of a new physical or chemical barrier, give preliminary indication of the effectiveness of physical barriers such as diaphragms or condoms, and provide information on unprotected intercourse among participants in a clinical trial who have been advised to use condoms. Candidate biomarkers of semen exposure fall into two broad categories: (1) biomarkers of seminal plasma, among which prostate-specific antigen (PSA) is the best characterized; and (2) biomarkers of spermatozoa and other cells present in semen. This paper, authored by a working group of investigators performing research in the field of semen biomarkers, summarizes the characteristics of an ideal semen biomarker, reviews preclinical and clinical data on existing and potential biomarkers, and outlines the steps that should be carried out to develop an improved biomarker of semen exposure.
Similar articles
- Biomarkers for evaluating vaginal microbicides and contraceptives: discovery and early validation.
Mauck CK. Mauck CK. Sex Transm Dis. 2009 Mar;36(3 Suppl):S73-5. doi: 10.1097/OLQ.0b013e3181994155. Sex Transm Dis. 2009. PMID: 19218892 Review. - Biomarkers of semen exposure.
Mauck CK. Mauck CK. Sex Transm Dis. 2009 Mar;36(3 Suppl):S81-3. doi: 10.1097/OLQ.0b013e318199413b. Sex Transm Dis. 2009. PMID: 19218891 Review. - TSPY4 is a novel sperm-specific biomarker of semen exposure in human cervicovaginal fluids; potential use in HIV prevention and contraception studies.
Jacot TA, Zalenskaya I, Mauck C, Archer DF, Doncel GF. Jacot TA, et al. Contraception. 2013 Sep;88(3):387-95. doi: 10.1016/j.contraception.2012.11.022. Epub 2012 Dec 7. Contraception. 2013. PMID: 23312930 - Evaluation of prostate-specific antigen as a quantifiable indicator of condom failure in clinical trials.
Walsh TL, Frezieres RG, Nelson AL, Wraxall BG, Clark VA. Walsh TL, et al. Contraception. 1999 Nov;60(5):289-98. doi: 10.1016/s0010-7824(99)00098-0. Contraception. 1999. PMID: 10717781 Clinical Trial.
Cited by
- Recent Semen Exposure Impacts the Cytokine Response and Bacterial Vaginosis in Women.
Mngomezulu K, Mzobe GF, Mtshali A, Osman F, Liebenberg LJP, Garrett N, Singh R, Rompalo A, Mindel A, Karim SSA, Karim QA, Baxter C, Ngcapu S. Mngomezulu K, et al. Front Immunol. 2021 Jun 9;12:695201. doi: 10.3389/fimmu.2021.695201. eCollection 2021. Front Immunol. 2021. PMID: 34177961 Free PMC article. - Semen: A modulator of female genital tract inflammation and a vector for HIV-1 transmission.
Jewanraj J, Ngcapu S, Liebenberg LJP. Jewanraj J, et al. Am J Reprod Immunol. 2021 Nov;86(5):e13478. doi: 10.1111/aji.13478. Epub 2021 Jun 16. Am J Reprod Immunol. 2021. PMID: 34077596 Free PMC article. Review. - Comparison of self-reported female condom failure and biomarker-confirmed semen exposure.
Walsh TL, Snead MC, St Claire BJ, Schwartz JL, Mauck CK, Frezieres RG, Blithe DL, Archer DF, Barnhart KT, Jensen JT, Nelson AL, Thomas MA, Wan LS, Weaver MA. Walsh TL, et al. Contraception. 2019 Nov;100(5):406-412. doi: 10.1016/j.contraception.2019.07.143. Epub 2019 Aug 2. Contraception. 2019. PMID: 31381878 Free PMC article. Clinical Trial. - Differential effects of depot medroxyprogesterone acetate administration on vaginal microbiome in Hispanic White and Black women.
Yang L, Hao Y, Hu J, Kelly D, Li H, Brown S, Tasker C, Roche NE, Chang TL, Pei Z. Yang L, et al. Emerg Microbes Infect. 2019;8(1):197-210. doi: 10.1080/22221751.2018.1563458. Emerg Microbes Infect. 2019. PMID: 30866773 Free PMC article. - Condom migration after introduction of pre-exposure prophylaxis among HIV-uninfected adolescents in South Africa: A cohort analysis.
Maljaars LP, Gill K, Smith PJ, Gray GE, Dietrich JJ, Gomez GB, Bekker LG. Maljaars LP, et al. South Afr J HIV Med. 2017 Sep 21;18(1):712. doi: 10.4102/sajhivmed.v18i1.712. eCollection 2017. South Afr J HIV Med. 2017. PMID: 29568635 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous